Primary and secondary cognition and other functional measures by treatment group: intensive vs guideline blood pressure lowering.

<p>Comparison by multiple regression of mean on-treatment score with adjustment for baseline value and age, systolic blood pressure, total cholesterol, time since stroke, treatment assignment (intensive vs lipid guideline lowering vs none).</p

Changes during follow-up in blood pressure and cholesterol by intensive vs guideline groups.

<p><b>Data are mean and standard error of mean</b>. (A) Systolic and diastolic blood pressure by intensive vs guideline blood pressure lowering groups. (B) Total cholesterol and LDL-cholesterol by intensive vs guideline lipid lowering groups.</p

CONSORT flow diagram of patient randomisation, follow up, outcome, and withdrawals.

<p>Screening for eligibility was not collected routinely. Data are number/Number (%).</p

Clinical characteristics at randomisation, by intensive vs guideline blood pressure and lipid lowering.

<p>Clinical characteristics at randomisation, by intensive vs guideline blood pressure and lipid lowering.</p

Changes in Addenbrooke’s Cognitive Examination-Revised score during follow-up for intensive vs guideline groups.

<p><b>Data are mean and standard error of mean</b>. (A) Intensive vs guideline blood pressure lowering. (B) Intensive vs guideline lipid lowering.</p

Primary and secondary cognition and other functional measures by treatment group: intensive vs guideline lipid lowering.

<p>Comparison by multiple regression of mean on-treatment score with adjustment for baseline value, age, systolic blood pressure, total cholesterol, time since stroke and treatment assignment (intensive vs guideline BP lowering).</p